Zhou, Hang https://orcid.org/0000-0002-7694-6391
Sealock, Julia M.
Sanchez-Roige, Sandra https://orcid.org/0000-0001-6137-5699
Clarke, Toni-Kim
Levey, Daniel F. https://orcid.org/0000-0001-8431-9569
Cheng, Zhongshan
Li, Boyang https://orcid.org/0000-0003-2808-9986
Polimanti, Renato
Kember, Rachel L.
Smith, Rachel Vickers https://orcid.org/0000-0002-7224-8916
Thygesen, Johan H.
Morgan, Marsha Y. https://orcid.org/0000-0001-6134-1026
Atkinson, Stephen R.
Thursz, Mark R.
Nyegaard, Mette https://orcid.org/0000-0002-2967-6624
Mattheisen, Manuel
Børglum, Anders D.
Johnson, Emma C. https://orcid.org/0000-0003-0394-777X
Justice, Amy C. https://orcid.org/0000-0003-0139-5502
Palmer, Abraham A. https://orcid.org/0000-0003-3634-0747
McQuillin, Andrew https://orcid.org/0000-0003-1567-2240
Davis, Lea K. https://orcid.org/0000-0001-5143-2282
Edenberg, Howard J. https://orcid.org/0000-0003-0344-9690
Agrawal, Arpana https://orcid.org/0000-0002-0313-793X
Kranzler, Henry R. https://orcid.org/0000-0002-1018-0450
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
Funding for this research was provided by:
Brain and Behavior Research Foundation (27835)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5T32GM080178)
DH | National Institute for Health Research
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1U01MH109514-01)
Office of Research and Development (#I01BX003341, #I01BX003341, #575B)
University College London Hospitals NHS Foundation Trust
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02DA32573)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA12870)
Article History
Received: 26 August 2019
Accepted: 16 April 2020
First Online: 25 May 2020
Competing interests
: H.R.K. is a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported over the past 3 years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, Arbor, and Amygdala Neurosciences. H.R.K. and J.G. are named as inventors on PCT patent application no. 15/878,640, entitled Genotype-guided dosing of opioid agonists, filed 24 January 2018.